NEW DELHI -- India on Tuesday announced it would allow a limited export of an anti-malaria drug seen as helpful in the treatment of the new coronavirus, a day after U.S. President Donald Trump warned of retaliation if New Delhi did not heed his request to supply the medicine to his country.
The South Asian country -- which is the largest producer of hydroxychloroquine, or HCQ, a drug touted by Trump as a "game-changer" in the fight against the coronavirus pandemic -- had on Apr. 4 said the export of the drug and formulations made from it would "remain prohibited, without any exception," as its own COVID-19 cases were beginning to spike.
